![]() Tuesday, 31st July 2018, 6:00pm CDT We are pleased to invite you to an analyst event on Tuesday, 31st July 2018 to discuss Roche's Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Chicago, Illinois (July 30-August 2, 2018). AACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world. The Analyst Event will start with an update on Roche Diagnostics HY 2018 results followed by a Q&A session on the Division and AACC highlights. | |
Date/Time: Tuesday, 31st July 2018 5:30pm Registration desk opens 6:00pm Start of meeting 7:15pm End of meeting followed by a buffet reception | |
Venue: Hilton Chicago Meeting room: Waldorf (third floor) 720 South Michigan Avenue Chicago, IL - 60605 ![]() | |
Presenter/Panelists: Roland Diggelmann, CEO Roche Diagnostics Paul Brown, Global Head of Roche Molecular Solutions Jack Phillips, Head of Roche Diagnostics North America Thomas Schinecker, Global Head of Centralised and Point of Care Solutions To register for the event, please follow the link (Password: Analyst2018). Analysts who cannot attend in person are invited to listen to the replay of the event which will be available the next day on the IR website. > click here Best regards, Karl Mahler Head of Investor Relations Birgit Masjost Investor Relations Officer |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com | Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com | Dr. Susann Manchado Phone: +41 61-68-75619 e-mail: susann.manchado@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com | |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
get the latest news and updates to your inbox.